We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BLFS market cap is 816.76M. The company's latest EPS is USD -1.4664 and P/E is -12.30.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 38.4M | 44.26M | 37.7M | 39.51M | 35.11M |
Operating Income | -11.42M | -51.65M | -13.61M | -16.2M | -13.1M |
Net Income | -1.28M | -50.23M | -13.71M | -10.2M | -29.13M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 27.37M | 48.09M | 119.16M | 161.76M | 145.46M |
Operating Income | -959k | -5.58M | -33.94M | -150.3M | -61.1M |
Net Income | -1.66M | 2.67M | -7.64M | -139.81M | -66.43M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 487.68M | 450.23M | 446.47M | 433.18M | 411.15M |
Total Liabilities | 79.43M | 86.04M | 88.36M | 81.05M | 79.14M |
Total Equity | 408.25M | 364.19M | 358.11M | 352.13M | 332.02M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 92.82M | 234.83M | 554.06M | 450.23M | 412.71M |
Total Liabilities | 49.36M | 29.58M | 73.92M | 86.04M | 75.05M |
Total Equity | 43.45M | 205.25M | 480.14M | 364.19M | 337.66M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -16.35M | -8.49M | -2.71M | -10.43M | -14.81M |
Investing | -43.22M | -58.12M | 2.93M | 12.22M | 13.88M |
Financing | 16.94M | 16.32M | -562k | 142k | 750k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 1.21M | 6.65M | -4.59M | -8.49M | -12.5M |
Investing | -27.02M | -24.72M | -13.19M | -58.12M | 17.84M |
Financing | 1.6M | 102.08M | -2.78M | 16.32M | 10.59M |
Market Cap | 816.76M |
Price to Earnings Ratio | -12.30 |
Price to Sales Ratio | 5.61 |
Price to Cash Ratio | 23.07 |
Price to Book Ratio | 2.42 |
Dividend Yield | - |
Shares Outstanding | 45.3M |
Average Volume (1 week) | 412.28k |
Average Volume (1 Month) | 381.52k |
52 Week Change | 4.34% |
52 Week High | 24.50 |
52 Week Low | 8.9201 |
Spread (Intraday) | 9 (45%) |
Company Name | BioLife Solutions Inc |
Address |
874 walker rd ste c dover, delaware 19904 |
Website | https://www.biolifesolutions.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions